112 related articles for article (PubMed ID: 25888939)
1. Human and murine prostate basal/stem cells are not direct targets of prolactin.
Sackmann-Sala L; Angelergues A; Boutillon F; d'Acremont B; Maidenberg M; Oudard S; Goffin V
Gen Comp Endocrinol; 2015 Sep; 220():133-42. PubMed ID: 25888939
[TBL] [Abstract][Full Text] [Related]
2. Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors.
Rouet V; Bogorad RL; Kayser C; Kessal K; Genestie C; Bardier A; Grattan DR; Kelder B; Kopchick JJ; Kelly PA; Goffin V
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15199-204. PubMed ID: 20699217
[TBL] [Abstract][Full Text] [Related]
3. Prolactin-induced prostate tumorigenesis.
Sackmann-Sala L; Goffin V
Adv Exp Med Biol; 2015; 846():221-42. PubMed ID: 25472541
[TBL] [Abstract][Full Text] [Related]
4. STAT5a/b Deficiency Delays, but does not Prevent, Prolactin-Driven Prostate Tumorigenesis in Mice.
Boutillon F; Pigat N; Sala LS; Reyes-Gomez E; Moriggl R; Guidotti JE; Goffin V
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31269779
[TBL] [Abstract][Full Text] [Related]
5. Prolactin-induced prostate tumorigenesis links sustained Stat5 signaling with the amplification of basal/stem cells and emergence of putative luminal progenitors.
Sackmann-Sala L; Chiche A; Mosquera-Garrote N; Boutillon F; Cordier C; Pourmir I; Pascual-Mathey L; Kessal K; Pigat N; Camparo P; Goffin V
Am J Pathol; 2014 Nov; 184(11):3105-19. PubMed ID: 25193592
[TBL] [Abstract][Full Text] [Related]
6. Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
Thomas LN; Merrimen J; Bell DG; Rendon R; Too CK
Prostate; 2015 Nov; 75(15):1726-36. PubMed ID: 26202060
[TBL] [Abstract][Full Text] [Related]
7. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT
Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813
[TBL] [Abstract][Full Text] [Related]
8. Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin.
Kindblom J; Dillner K; Sahlin L; Robertson F; Ormandy C; Törnell J; Wennbo H
Endocrinology; 2003 Jun; 144(6):2269-78. PubMed ID: 12746285
[TBL] [Abstract][Full Text] [Related]
9. Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting.
Thomas LN; Merrimen J; Bell DG; Rendon R; Goffin V; Too CK
Prostate; 2014 May; 74(7):732-42. PubMed ID: 24615730
[TBL] [Abstract][Full Text] [Related]
10. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
Xu X; Kreye E; Kuo CB; Walker AM
Cancer Res; 2001 Aug; 61(16):6098-104. PubMed ID: 11507059
[TBL] [Abstract][Full Text] [Related]
11. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge.
Goffin V
Pharmacol Ther; 2017 Nov; 179():111-126. PubMed ID: 28549597
[TBL] [Abstract][Full Text] [Related]
12. Changes in prolactin receptor location in prostate tumors.
López Fontana G; Rey L; Santiano F; López Fontana R; López Laur JD; Zyla L; Valdemoros P; Guerrero-Giménez ME; Fernández-Muñoz JM; Gómez S; Bruna F; Guglielmi JM; Carón R; López Fontana C
Arch Esp Urol; 2021 May; 74(4):419-426. PubMed ID: 33942735
[TBL] [Abstract][Full Text] [Related]
13. Prolactin and the prolactin receptor: new targets of an old hormone.
Harris J; Stanford PM; Oakes SR; Ormandy CJ
Ann Med; 2004; 36(6):414-25. PubMed ID: 15513293
[TBL] [Abstract][Full Text] [Related]
14. Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures.
Ueda EK; Huang K; Nguyen V; Ferreira M; Andre S; Walker AM
Cell Tissue Res; 2011 Nov; 346(2):175-89. PubMed ID: 22081226
[TBL] [Abstract][Full Text] [Related]
15. S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells.
Wu W; Ginsburg E; Vonderhaar BK; Walker AM
Cancer Res; 2005 Aug; 65(16):7509-15. PubMed ID: 16103106
[TBL] [Abstract][Full Text] [Related]
16. Cell Plasticity in a Mouse Model of Benign Prostate Hyperplasia Drives Amplification of Androgen-Independent Epithelial Cell Populations Sensitive to Antioxidant Therapy.
Dos Santos L; Carbone F; Pacreau E; Diarra S; Luka M; Pigat N; Baures M; Navarro E; Anract J; Barry Delongchamps N; Cagnard N; Bost F; Nemazanyy I; Petitjean O; Hamaï A; Ménager M; Palea S; Guidotti JE; Goffin V
Am J Pathol; 2024 Jan; 194(1):30-51. PubMed ID: 37827216
[TBL] [Abstract][Full Text] [Related]
17. Correlation of prolactin levels and PRL-receptor expression with Stat and Mapk cell signaling in the prostate of long-term sexually active rats.
Rojas-Durán F; Pascual-Mathey LI; Serrano K; Aranda-Abreu GE; Manzo J; Soto-Cid AH; Hernandez ME
Physiol Behav; 2015 Jan; 138():188-92. PubMed ID: 25446202
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathways: blockade of the PRLR signaling pathway as a novel antihormonal approach for the treatment of breast and prostate cancer.
Damiano JS; Wasserman E
Clin Cancer Res; 2013 Apr; 19(7):1644-50. PubMed ID: 23515410
[TBL] [Abstract][Full Text] [Related]
19. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade.
Li H; Ahonen TJ; Alanen K; Xie J; LeBaron MJ; Pretlow TG; Ealley EL; Zhang Y; Nurmi M; Singh B; Martikainen PM; Nevalainen MT
Cancer Res; 2004 Jul; 64(14):4774-82. PubMed ID: 15256446
[TBL] [Abstract][Full Text] [Related]
20. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
Jabbour HN; Critchley HO; Boddy SC
J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
